Activating Compound | Comment | Organism | Structure |
---|---|---|---|
IFNgamma | activates AMPK by phosphorylation of Thr172, independent of intracellular energy (ATP) levels. Phosphatidylinositol 3'-kinase inhibition by LY294002 partially prevents IFNgamma-induced activation of AMPK | Homo sapiens |
Application | Comment | Organism |
---|---|---|
medicine | implication of AMPK in the pathogenesis of chronic intestinal inflammatory conditions, such as inflammatory bowel disease | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
6-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine | compound C, inhibition of AMPK prevents at 0.05 mM, in part, the IFNgamma-induced decrease in transepithelial electrical resistance, the increased epithelial permeability, the decreased transepithelial electrical resistance, and the decrease in occludin and zonula occludens-1 caused by IFNgamma treatment of T84 cells | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
T-84 cell | intestinal epithelial cell | Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
AMP-activated protein kinase | - |
Homo sapiens |
AMPK | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | siRNA knockdown of AMPK, which ameliorates the IFNgamma-induced increase in epithelial permeability and decrease in transepithelial electrical resistance | down |
General Information | Comment | Organism |
---|---|---|
physiological function | role for AMPK, in concert with other signals induced by IFNgamma, in mediating reduced epithelial barrier function in a cell model of chronic intestinal inflammation | Homo sapiens |